Dermatology Research and Practice / 2013 / Article / Tab 1 / Clinical Study
Evaluation of the Quantitative and Qualitative Alterations in the Fatty Acid Contents of the Sebum of Patients with Inflammatory Acne during Treatment with Systemic Lymecycline and/or Oral Fatty Acid Supplementation Table 1 Distribution of patients with acne vulgaris according to the outcome of gas chromatography carried out on D0.
Fatty acid
Average% (standard deviation) Median% (min.–max.) C12:0 0.32 (0.44) 0 (0.00–1.39) C13:0 0.02 (0.08) 0 (0.00–0.45) C14:0 5.79 (1.85) 5.94 (1.22–10.38) C14:1 0.33 (0.41) 0 (0.00–1.16) C15:0 3.77 (1.11) 3.97 (0.88–5.45) C15:1 0.01 (0.05) 0 (0.00–0.34 ) C16:0 17.92 (5.31) 17.66 (4.83–29.25) C16:1 15.63 (4.86) 16.73 (2.83–24.92) C17:0 0.69 (0.57) 0.87 (0.00–1.59) C17:1 2.23 (0.93) 2.36 (0.00–4.82) C18:0 3.74 (1.27) 3.50 (1.77–6.62) C18:1n9c+C18:1n9t 9.50 (2.59) 9.83 (3.33–15.30) C18:2n6c 0.32 (0.51) 0 (0.00–1.80) C18:2n6t 0.53 (1.26) 0 (0.00–5.45) C18:2n6c+C18:2n6t 0.85 (1.31) 0 (0.00–5.45) C18:3n6 0.20 (0.73) 0 (0.00–3.27) C18:3n3 0.52 (1.29) 0 (0.00–4.44) C20:0 1.62 (5.09) 0 (0.00–26.83) C20:1 1.78 (4.71) 0 (0.00–22.09) C20:2 0.12 (0.79) 0 (0.00–4.99) C21:0 0.02 (0.10) 0 (0.00–0.66) C20:5n3 0.12 (0.75) 0 (0.00–4.74) C22:0 0.52 (1.47) 0 (0.00–6.35) C22:1n9 0.14 (0.69) 0 (0.00–4.30) C24:0 0.27 (0.47) 0 (0.00–1.42) Squalene 13.34 (4.91) 12.88 (2.88–23.15) Total identified 79.46 (14.42) 84.44 (40.44–100)